Filing Details

Accession Number:
0001140361-10-016109
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2010-04-12 13:00:00
Reporting Period:
2010-04-08
Filing Date:
2010-04-12
Accepted Time:
2010-04-12 16:19:58
Original Submission Date:
2009-09-08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1441848 Facet Biotech Corp FACT Pharmaceutical Preparations (2834) 263070657
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
899869 A Seth Klarman 10 St. James Ave.
Suite 1700
Boston MA 02116
No No Yes No
1061088 Sak Corp 10 St James Avenue
Ste 1700
Boston MA 02116
No No Yes No
1061768 Baupost Group Llc/Ma 10 St James Ave
Suite 1700
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Per Share Disposition 2010-04-08 500,000 $26.96 1,500,000 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. (Baupost), SAK Corporation and Seth A. Klarman. Baupost is a registered investment adviser under the Investment Advisers Act of 1940, as amended, and acts as an investment adviser to certain investment limited partnerships. Securities reported on this Form 4 as being beneficially owned by Baupost include securities held by such investment limited partnerships, for which Baupost is the general partner and investment adviser. SAK Corporation is the manager of Baupost. Mr. Klarman is the sole director and sole officer of SAK Corporation and a controlling person of Baupost. The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interests therein.